Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9068314.
- Also identified by PMC identifier 1717065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The response to the bisphosphonate, pamidronate, is reported in a child with osteogenesis imperfecta who had recurrent symptomatic hypercalcaemia after immobilisation following fractures. Oral clodronate was effective in the prevention of immobilisation hypercalcaemia in the same child. The bisphosphonates may have other roles in osteogenesis imperfecta by decreasing bone turnover.
Medical subject headings
- Diphosphonates
- Hypercalcemia
- Osteogenesis Imperfecta